| Evelina Kartsimaris, MD | |
|
301 Yadkin St, Albemarle, NC 28001-3441 | |
| (704) 984-4365 | |
| Not Available |
| Full Name | Evelina Kartsimaris |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 301 Yadkin St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184705220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2007-00032 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Evelina Kartsimaris, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Evelina Kartsimaris, MD 301 Yadkin St, Albemarle, NC 28001-3441 Ph: (704) 984-4365 |
News Archive
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.
An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.
An antiparasitic agent used to treat African sleeping sickness might someday be used to prevent nonmelanoma skin cancers. Researchers found that DFMO, or α-difluoromethylornithine, still appeared to protect against nonmelanoma skin cancers years after people stopped taking the drug, according to a poster presented at the 10th AACR International Conference on Frontiers in Cancer Prevention Research, held Oct. 22-25, 2011.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to its infrequent dosing and positive efficacy, nearly 90 percent of surveyed neurologists indicate they will prescribe Merck Serono/EMD Serono's oral cladribine for the treatment of multiple sclerosis.
A new study published in Bioscience Hypotheses, a recently launched Elsevier journal, proposes that some people suffering from Alzheimer's disease experience a reduction in their high blood pressure because of cognitive decline.
› Verified 8 days ago
Stacey Evelyn Furr, FNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 | |
Kevin Antonio Lopez-shirley, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Carolinas Hospitalist Group - Stanly, Albemarle, NC 28001 Phone: 704-984-4365 Fax: 704-983-7856 | |
Prashant Dhirajlal Bhensdadia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 | |
Syed Fakruddin Ali Ahmed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 Fax: 704-983-7856 | |
Ajay Gupta, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 | |
Marshall Kamau Rashaad Crawford, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365 |